Key facts
- Notable investors include BioLab Holdings.
- Status: Acquired/Merged (Operating Subsidiary).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Terraplasma medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Terraplasma medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Terraplasma medical
Developer of a medical device intended to treat chronic and acute wounds with cold atmospheric plasma. The company's medical device uses advanced plasma technology, providing a pain-free, non-invasive method for wound care and dermatology, without side effects, enabling health care professionals to set new standards in the treatment of acute and chronic wounds that are safe, effective, and scientifically sound.
- Sector
- Healthcare
- HQ
- Garching, Germany
- Founded
- 2016
- Employees
- 16
- Website
- terraplasma-medical.com/
- Ownership
- Acquired/Merged (Operating Subsidiary)
Terraplasma medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Terraplasma medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Terraplasma medical in its N-PORT filings yet. We sweep new filings monthly.